<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JACEN</journal-id><journal-title-group><journal-title>Journal of Agricultural Chemistry and Environment</journal-title></journal-title-group><issn pub-type="epub">2325-7458</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jacen.2022.111002</article-id><article-id pub-id-type="publisher-id">JACEN-114738</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject><subject> Earth&amp;Environmental Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Study of Biological Activity and Toxicity of Thiosemicarbazides Carbohydrate Derivatives by &lt;i&gt;in Silico&lt;/i&gt;, &lt;i&gt;in Vitro&lt;/i&gt; and &lt;i&gt;in Vivo&lt;/i&gt; Methods
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Baktygul</surname><given-names>Ernazarova</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Taitokur</surname><given-names>Zhusubaliev</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zarylkan</surname><given-names>Asilbek kyzy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aida</surname><given-names>Bakirova</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gulsara</surname><given-names>Zhusupbaeva</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Orozby</surname><given-names>Akparalieva</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhypargul</surname><given-names>Abdullaeva</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nasibakhon</surname><given-names>Razykova</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Asilkan</surname><given-names>Dzhumanazarova</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Galina</surname><given-names>Apryshko</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alina</surname><given-names>Orozmatova</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Science and Research Department, Osh State University, Osh, Kyrgyzstan</addr-line></aff><aff id="aff2"><addr-line>Zhalal-Abad Scientific Center, South Department Academy of Sciences, Zhalal-Abad, Kyrgyzstan</addr-line></aff><aff id="aff5"><addr-line>National Medical Research Center of Oncology Named after N.N. Blokhin, Moscow, Russia</addr-line></aff><aff id="aff4"><addr-line>Institute of Chemistry and Phytotechnology, National Academy of Sciences, Bishkek, Kyrgyzstan</addr-line></aff><aff id="aff1"><addr-line>Department of Pharmacy and Medical-Biological Disciplines, Zhalal-Abad State University, Zhalal-Abad, Kyrgyzstan</addr-line></aff><pub-date pub-type="epub"><day>19</day><month>01</month><year>2022</year></pub-date><volume>11</volume><issue>01</issue><fpage>15</fpage><lpage>23</lpage><history><date date-type="received"><day>13,</day>	<month>December</month>	<year>2021</year></date><date date-type="rev-recd"><day>17,</day>	<month>January</month>	<year>2022</year>	</date><date date-type="accepted"><day>20,</day>	<month>January</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Computer analysis of N-(
  <em>β</em>-D-galactopyranosyl)-thiosemicarbazide compounds by 
  <em>in silico </em>method revealed high probability of antibacterial (antimycobacterial), anti-tuberculosis (antituberculosic), antiviral (Influenza), antitumor (antineoplastic) 9 &gt; Pa &gt; 0.5 and with a low probability of cytotoxic/cytostatic (cytostatic/cytotoxic) activities. An experimental study by
  <em> in vitro</em> and
  <em> in vivo</em> methods allowed us to conclude that studied new synthetic compound N-(
  <em>β</em>-D-galactopyranosyl)-thiosemicarbazide in the studied concentrations has a pronounced bactericidal and bacteriostatic effects.
 
</p></abstract><kwd-group><kwd>Biological Activity</kwd><kwd> Synthesis</kwd><kwd> Urea</kwd><kwd> Carbohydrate</kwd><kwd> Compounds</kwd><kwd> Hyperurcemia</kwd><kwd> Ototoxicity</kwd><kwd> Testing</kwd><kwd> Toxicity</kwd><kwd> Anti Tuberculosis</kwd><kwd> Antitumor</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>In recent years, computer programs have been widely used to predict biological activity and toxic effects of organic compounds. Among the programs that can be used to predict various types of biological activity is the PASS program developed by the V.N. Orekhovich RAMS [<xref ref-type="bibr" rid="scirp.114738-ref1">1</xref>].</p><p>The use of the PASS program makes it possible, among a wide group of analyzed compounds, to select those that with a high degree of probability have the required types of biological activity and, at the same time, with a low degree of probability, give undesirable toxic effects. When choosing promising compounds, not only main, but also side pharmacological effects were considered.</p><p>The fundamental problem of the relationship between the biological activity and the structure of chemical compounds and the search on this basis for new highly active medicinal substances is of fundamental importance for modern pharmacology. For this purpose, we have developed methods for the preparation of carbohydrate derivatives of thiosemicarbazides using the Lawesson reagent [<xref ref-type="bibr" rid="scirp.114738-ref2">2</xref>].</p><p>Molecule structure have an important role in the pharmacological activity of thiosemicarbazide derivatives [<xref ref-type="bibr" rid="scirp.114738-ref3">3</xref>], compounds having a pyridine ring and a thiosemicarbazide system as a well-known carrier antituberculosis agent with biological action were synthesized [<xref ref-type="bibr" rid="scirp.114738-ref4">4</xref>].</p></sec><sec id="s2"><title>2. Research Methods and Materials</title><p>In this article, study of biological activity and toxicity of thiosemicarbazides carbohydrate derivatives was conducetd by in silico, in vitro and in vivo methods based on our previous works [<xref ref-type="bibr" rid="scirp.114738-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref6">6</xref>]. Acute toxicity of N-(β-D-galactopyranosyl)-thiosemicarbazide was tested in the Biotechnology and Chemistry, Bacteriology Departments of Kyrgyz Republican Center for Diagnostics and Expertise.</p></sec><sec id="s3"><title>3. Results and Discussions</title><sec id="s3_1"><title>3.1. Possibility Assessment in Using the PASS Сomputer System for Biological Activity</title><p>The results of assessing the possibility of using the PASS computer system to predict biological activity by structural formula for chemical compounds as a stage in pre-experimental screening of new substances are presented below. <xref ref-type="table" rid="table1">Table 1</xref> shows the results of predicting 14 types of biological activity in the form of values of the probability of presence (Pa) and the probability of absence of this activity (Pi).</p><p>With the studied virtual compounds in N-(β-D-galactopyranosyl)-thiosemicarbazide, antibacterial (antimycobacterial), anti-tuberculosic (antituberculosic), antiviral (antiviral (Influenza)), antitumor (antineoplastic &gt;) activity of the compounds are predicted with a high probability (0.9 &gt; 0.5) and with a low probability of cytotoxic/cytostatic (Cytostatic/Cytotoxic) activity. Next, we analyzed possible toxic effects with a probability Pa &gt; 0.5 for compounds 1, 2 based on their structural formulas (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>The results of computer predictions, we found that compounds 1.2 are predicted to have increased side effects, the ability to cause hyperuricemia an increased level of uric acid in the blood. Among the studied compounds, promising substances for experimental research identified with a high probability of antibacterial activity in N-(β-D-galactopyranosyl)-thiosemicarbazide compounds (Pa/Pi 0.799/0.004 antimycobacterial).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Results of glycosylthiosemicarbazides biological activity</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No.</th><th align="center" valign="middle" >Compound name</th><th align="center" valign="middle" >Structure</th><th align="center" valign="middle" >Pharmacological effect results Pa Pi activity</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >N-(β-D-xylopyranosil)-thiosemicarbazide</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="/html.scirp.org/file/2-2750517x3.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >6 of 464 Possible Pharmacological Effects at Pa &gt; 0.500 0.654 0.007 Antimycobacterial 0.637 0.037 Antineoplastic 0.593 0.005 Antidiabetic symptomatic 0.576 0.004 Antineoplastic (small cell lung cancer) 0.548 0.005 Restenosis treatment 0.523 0.010 Antituberculosic</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >N-(β-D-galactopyranosil)-thiosemicarbazide</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="/html.scirp.org/file/2-2750517x4.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >14 of 464 Possible Pharmacological Effects at Pa &gt; 0.500 0.799 0.004 Antimycobacterial 0.718 0.004 Antituberculosic 0.700 0.004 Restenosis treatment 0.679 0.007 Antiviral (Influenza) 0.685 0.029 Antineoplastic 0.628 0.013 Antiviral (Poxvirus) 0.586 0.005 Antidiabetic symptomatic 0.543 0.005 Antiviral 0.564 0.028 Immunostimulant 0.549 0.014 DNA synthesis inhibitor 0.539 0.005 Antioxidant 0.544 0.013 Antibacterial 0.511 0.024 Cytostatic 0.508 0.022 Antidiabetic</td></tr></tbody></table></table-wrap></sec><sec id="s3_2"><title>3.2. Studies on Acute Toxicity of N-(β-D-Galactopyranosyl)-Thiosemicarbazide</title><p>The acute toxicity of N-(β-D-galactopyranosyl)-thiosemicarbazide was tested in the Biotechnology and Chemistry, Bacteriology Departments of Kyrgyz Republican Center for Diagnostics and Expertise. Study aim of acute toxicity was to determine tolerable, toxic and lethal doses of a pharmacological substance and cause of animals’ death [<xref ref-type="bibr" rid="scirp.114738-ref6">6</xref>].</p><p>When studying the toxicology of newly synthesized compounds, the first prerequisite is to determine the parameters of acute toxicity. These indicators are necessary to establish the degree of hazard of a chemical, as well as, for further research, where knowledge of the degree of acute toxicity is required.</p><p>Acute toxicity of pharmacological substances [<xref ref-type="bibr" rid="scirp.114738-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref8">8</xref>] is determined by the following parameters: LD<sub>0</sub> is the maximum tolerated dose, LD<sub>50</sub> is an average lethal dose, LD<sub>100</sub> is minimum lethal dose [<xref ref-type="bibr" rid="scirp.114738-ref9">9</xref>]. LD<sub>16</sub> and LD<sub>84</sub> are also determined to establish the confidence limits of LD<sub>50</sub> the average lethal dose.</p><p>There are a number of classifications of chemical substances for the assessment of acute toxicity [<xref ref-type="bibr" rid="scirp.114738-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref12">12</xref>]. To assess the toxicity of antiparasitic drugs, the classification according to [<xref ref-type="bibr" rid="scirp.114738-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref13">13</xref>] is more suitable. Based on the foregoing,</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Results of glycosylthiosemicarbazides toxic effects</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No.</th><th align="center" valign="middle" >Compound name</th><th align="center" valign="middle" >Structure</th><th align="center" valign="middle" >Pharmacological effect results Pa Pi activity</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >N-(β-D-xylopyranosil)-thiosemicarbazide</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="/html.scirp.org/file/2-2750517x5.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >9 of 321 Possible Toxic and Adverse Effects at Pa &gt; 0.500 0.747 0.010 Hyperuricemia 0.680 0.046 Neuritis 0.664 0.052 Renal insufficiency 0.643 0.031 Acidosis, metabolic 0.628 0.042 Acidosis 0.640 0.067 Anemia, hemolytic 0.640 0.067 Hyperactivity 0.574 0.111 Dysesthesia 0,.512 0.089 Optic neuritis</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >N-(β-D-galactopyranosil)-thiosemicarbazide</td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="/html.scirp.org/file/2-2750517x6.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >23 of 321 Possible Toxic and Adverse Effects at Pa &gt; 0.500 0.818 0.005 Hyperuricemia 0.689 0.039 Diarrhea 0.682 0.047 Renal insufficiency 0.682 0.049 Myocardial ischemia 0.652 0.048 Hypoxia 0.628 0.035 Optic neuritis 0.620 0.042 Psychoses 0.605 0.027 Peripheral neuropathy 0.599 0.046 Optic neuropathy 0,596 0.080 Hyperactivity 0.549 0.051 Ototoxicity 0.679 0.007 Antiviral (Influenza) 0.685 0.029 Antineoplastic 0.628 0.013 Antiviral (Poxvirus) 0.586 0.005 Antidiabetic symptomatic 0.543 0.005 Antiviral 0.564 0.028 Immunostimulant 0,549 0.014 DNA synthesis inhibitor 0.539 0.005 Antioxidant 0.544 0.013 Antibacterial 0.511 0.024 Cytostatic 0.508 0.022 Antidiabetic</td></tr></tbody></table></table-wrap><p>we studied the acute toxicity parameters of a new carbohydrate derivative of thiosemicarbazides N-(β-D-galactopyranosyl)-thiosemicarbazide.</p><p>The experiments were carried out on 36 clinically healthy white mice of both sexes with a live weight 18 to 22 grams. The substance was administered to animals orally in the form of a 10% solution using a syringe equipped with a special metal probe, in various doses. Control animals received an appropriate volume of sodium chloride saline solution.</p><p>During the experiment, the animals were not limited to feeding and watering. The experiments lasted 12 days, during which the general condition, the nature and degree of chemical toxicity, the time of death of the experimental and control mice were observed. The corpses of the dead experimental animals were subjected to a visual pathoanatomical autopsy to establish the degree and nature of organ damage and the causes of death.</p><p>Statistical processing of digital materials was carried out by the method [<xref ref-type="bibr" rid="scirp.114738-ref14">14</xref>], modified [<xref ref-type="bibr" rid="scirp.114738-ref15">15</xref>], using ordinary graph paper [<xref ref-type="bibr" rid="scirp.114738-ref16">16</xref>].</p><p>The results of the experiments showed that the nature and degree of chemical toxicity in white mice were in direct proportion to the doses of the studied compound. Signs of poisoning when giving large doses appeared for the first time within minutes and were often fatal within 1 to 2 hours after giving. They were mainly expressed in the manifestation of an excited state (anxiety, increased reaction to external stimuli, tachycardia, rapid breathing), from feed tons of water.</p><p>Then this condition passed on to progressive oppression, leading to complete prostration. Breathing is shallow, frequent, and intermittent. Rapid palpitations, sometimes turning into arrhythmias. The death of animals that received large toxic doses of the compound occurred mainly on the first day of administration of the substance. The surviving animals showed mild diarrhea and poor appetite, which soon subsided.</p><p>The postmortem autopsy of dead white mice revealed: the back of corpses is soiled with liquid feces; the brain is swollen, hyperemic; the mucous membrane of the stomach and intestines is strongly hyperemic, in some places there are areas of extensive hemorrhage and necrosis; the liver is enlarged, dark red in color, its parenchyma is softened; kidneys of normal size, multiple punctate hemorrhages under the membrane; the heart is flabby, the myocardium is soft, the ventricles contain dark red blood clots, there are punctate hemorrhages on the epicardium and endocardium; the lungs are swollen of a dark red color, the blood vessels are dilated.</p><p>The results of statistical processing of digital experimental data showed that (<xref ref-type="table" rid="table3">Table 3</xref>) the maximum tolerated dose (LD<sub>50</sub>) of N-(β-D-galactopyranosil)-thiosemicarbazide for white mice was 400 mg/kg, LD<sub>16</sub> was 754 mg/kg, the average lethal dose LD<sub>50</sub> was 1134 (957 &#177; 1311) mg/kg, LD<sub>84</sub> was 1534 mg/kg and absolutely lethal dose (LD<sub>100</sub>) was 2000 mg/kg.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Acute toxicity parameters of N-(β-D-galactopyranosyl)–thiosemicarbazide tested on mice</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Dose, ml/mice quantity</th><th align="center" valign="middle"  rowspan="2"  >Mice quanlity</th><th align="center" valign="middle"  colspan="2"  >Results</th><th align="center" valign="middle"  rowspan="2"  >Acute toxicity parameters, mg/kg</th></tr></thead><tr><td align="center" valign="middle" >Extinct</td><td align="center" valign="middle" >Survived</td></tr><tr><td align="center" valign="middle" >400</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >6</td><td align="center" valign="middle"  rowspan="6"  >LD<sub>0</sub> = 400 LD<sub>16</sub> = 754 LD<sub>50</sub> = 1134 (957 &#177; 1311) LD<sub>84</sub> = 1534 LD<sub>100</sub> = 2000</td></tr><tr><td align="center" valign="middle" >800</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5</td></tr><tr><td align="center" valign="middle" >1200</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >1600</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >2000</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Control</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >6</td></tr></tbody></table></table-wrap><p>The results obtained indicate that, according to the current classification of the hazard of chemotherapeutic drugs according to the degree of impact on the body (GOST 12.1.007-76), N-(β-D-galactopyranosyl)-thiosemicarbazide belongs to substances of III class of moderate hazard [<xref ref-type="bibr" rid="scirp.114738-ref17">17</xref>] confirms the prospects for further study of this compound in this direction.</p></sec><sec id="s3_3"><title>3.3. Study of Antibacterial Activity of N-(β-D-Galactopyranosyl)-Thiosemicarbazide</title><p>The experiments were carried out at the Department of Biotechnology and Chemistry and at the Department of Bacteriology of the Kyrgyz Republican Center for Diagnostics and Expertise by the in vitro method using generally accepted bacteriology techniques [<xref ref-type="bibr" rid="scirp.114738-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.114738-ref22">22</xref>].</p><p>For this, by means of serial dilutions with distilled water (1:10; 1:20; 1:40 … 1:2650), various concentrations of the substance were prepared, the bactericidal effect of which was studied by plating Salmonella infection of lambs on agar-agar in Petri dishes (Salmonellatyphimurium, 04), salmonellosis of calves (Salmonella Dublin, 09) and colipathogenic serotypes of Escherichia coli (Escherichiacoli 055, 026) and the addition of 0.1 ml of each dilution of the substance.</p><p>The results were taken into account after daily cultivation in a thermostat at t = 37˚C, by measuring the diameters of the zones (in mm), and by the absence of microorganism growth at the place where the compound was applied. Distilled water (i.e., solvent) served as a control.</p><p>The results of experiments carried out on a solid nutrient medium show (<xref ref-type="table" rid="table4">Table 4</xref>) that the test compound showed bactericidal activity against the selected microbial cultures, although no pronounced species specificity was observed in its action.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Bactericidal activity of N-(β-D-galactopyranosyl)-thiosemicarbazide in a dense nutrient medium (agar-agar)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Microorganisms</th><th align="center" valign="middle"  colspan="9"  >Studied substance dilutions</th></tr></thead><tr><td align="center" valign="middle" >1:10</td><td align="center" valign="middle" >1:20</td><td align="center" valign="middle" >1:40</td><td align="center" valign="middle" >1:80</td><td align="center" valign="middle" >1:160</td><td align="center" valign="middle" >1:380</td><td align="center" valign="middle" >1:640</td><td align="center" valign="middle" >1:1280</td><td align="center" valign="middle" >1:2560</td></tr><tr><td align="center" valign="middle"  colspan="10"  >N-(β-D-galactopyranosil)-thiosemicarbazide</td></tr><tr><td align="center" valign="middle" >Sal. typhimurium 04</td><td align="center" valign="middle" >22*</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Sal. dublin 09</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Esch. coli 055</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Esch. coli 026</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle"  colspan="10"  >Distilled water</td></tr><tr><td align="center" valign="middle" >Sal. typhimurium 04</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Sal. dublin 09</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Esch. coli 055</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Esch. coli 026</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr></tbody></table></table-wrap><p>*numbers show diameter of microorganisms’ growth zones (in mm).</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Bacteriostatic activity of N-(β-D-galactopyranosyl)-thiosemicarbazide in meat peptone broth</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Microorganisms</th><th align="center" valign="middle"  colspan="9"  >Studied substance dilutions</th></tr></thead><tr><td align="center" valign="middle" >1:10</td><td align="center" valign="middle" >1:20</td><td align="center" valign="middle" >1:40</td><td align="center" valign="middle" >1:80</td><td align="center" valign="middle" >1:160</td><td align="center" valign="middle" >1:380</td><td align="center" valign="middle" >1:640</td><td align="center" valign="middle" >1:1280</td><td align="center" valign="middle" >1:2560</td></tr><tr><td align="center" valign="middle"  colspan="9"  >N-(β-D-galactopyranosil)-thiosemicarbazide</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Sal. typhimurium 04</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Sal. dublin 09</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Esch. coli 055</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Esch. coli 026</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >−</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle"  colspan="10"  >Distilled water</td></tr><tr><td align="center" valign="middle" >Sal. typhimurium 04</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Sal. dublin 09</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Esch. coli 055</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr><tr><td align="center" valign="middle" >Esch. coli 026</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td><td align="center" valign="middle" >+</td></tr></tbody></table></table-wrap><p>− lack of growth, + presence of growth.</p><p>The bacteriostatic activity of the substance was studied by diluting it in mesopatamia broth at the same concentrations as in the previous experiment, followed by sowing pure cultures in it. The results of this series of experiments showed (<xref ref-type="table" rid="table5">Table 5</xref>) that the bacteriostatic substance acts on Esch. coli 055 from a dilution of 1:380, for other cultures from a dilution of 1:640.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>Experiment results after analyses allow concluding, that studied new synthetic compound N-(β-D-galactopyranosyl)-thiosemicarbazide in studied concentrations has a pronounced bactericidal and bacteriostatic effects. Thus, it was proved that experimental study of biological activity coincided with the prediction data, which is an average accuracy of computer prediction with sliding control about 90%.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Ernazarova, B., Zhusubaliev, T., Asilbek kyzy, Z., Bakirova, A., Zhusupbaeva, G., Akparalieva, O., Abdullaeva, Z., Razykova, N., Dzhumanazarova, A., Apryshko, G. and Orozmatova, A. (2022) Study of Biological Activity and Toxicity of Thiosemicarbazides Carbohydrate Derivatives by in Silico, in Vitro and in Vivo Methods. Journal of Agricultural Chemistry and Environment, 11, 15-23. https://doi.org/10.4236/jacen.2022.111002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.114738-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Understanding Chemical-Biological Interactions. PASS Online. http://way2drug.com/PassOnline/index.php</mixed-citation></ref><ref id="scirp.114738-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ernazarova, B.K. (2013) Thionation of Carbohydrate Derivatives of Semicarbazides. Collection of Materials of the XXI International Scientific and Practical Conference “Science and Modernity-2013”, Novosibirsk, 182-186.</mixed-citation></ref><ref id="scirp.114738-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Popovici, C., Pavel, C.M., Sunel, V., Cheptea, C., Dimitriu, D.G., Dorohoi, D.O., David, D., et al. (2021) Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity. International Journal of Molecular Sciences, 22, Article ID: 12139. https://doi.org/10.3390/ijms222212139</mixed-citation></ref><ref id="scirp.114738-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Pitucha, M., Karczmarzyk, Z., Swatko-Ossor, M., Wysocki, W., Wos, M., Chudzik, K., Ginalska, G. and Fruzinski, A. (2019) Synthesis, in Vitro Screening and Docking Studies of New Thiosemicarbazide Derivatives as Antitubercular Agents. Molecules, 24, Article No. 251. https://doi.org/10.3390/molecules24020251</mixed-citation></ref><ref id="scirp.114738-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ernazarova, B., Bakirova, A., Dzhumanazarova, A., Abdullaeva, Z., Berkmamatov, S. and Zhusupbaeva, G. (2020) Thionization Method of Glycosyl Urea and Carbamide Sugars. International Journal of Organic Chemistry, 10, 111-122. https://doi.org/10.4236/ijoc.2020.103008</mixed-citation></ref><ref id="scirp.114738-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ernazarova, B., Dzhumanazarova, A., Bakirova, A., Abdullaeva, Z., Zhusupbaeva, G., Asylbek Kyzy, Z. and Arzybaev, M. (2020) Synthesis, Assessment of Biological Activity and Toxicity for N-(β-D-Glycopyranosyl)-Thiosemicarbazides. International Journal of Organic Chemistry, 10, 159-169. https://doi.org/10.4236/ijoc.2020.104012</mixed-citation></ref><ref id="scirp.114738-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Turner, R.A. (1967) Screening Methods of Pharmacology. Academic Press, New York, 111-112.</mixed-citation></ref><ref id="scirp.114738-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Guengerich, F.P. (2011) Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development. Drug Metabolism and Pharmacokinetics, 26, 3-14. https://doi.org/10.2133/dmpk.dmpk-10-rv-062</mixed-citation></ref><ref id="scirp.114738-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Liakoni, E., Dolder, P.C., Rentsch, K.M. and Liechti, M.E. (2016) Presentations Due to Acute Toxicity of Psychoactive Substances in an Urban Emergency Department in Switzerland: A Case Series. BMC Pharmacology &amp; Toxicology, 17, Article No. 25. https://doi.org/10.1186/s40360-016-0068-7</mixed-citation></ref><ref id="scirp.114738-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Walum, E. (1998) Acute Oral Toxicity. Environmental Health Perspectives, 106, 497-503. https://doi.org/10.1289/ehp.98106497</mixed-citation></ref><ref id="scirp.114738-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Barenboim, G.M. and Malenkov, A.G. (1986) Biological Active Substances. Science, Moscow, 284 p.</mixed-citation></ref><ref id="scirp.114738-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Gimenez-Bastida, J.A., Martinez Carreras, L., Moya-Pérez, A. and Laparra Llopis, J.M. (2018) Pharmacological Efficacy/Toxicity of Drugs: A Comprehensive Update about the Dynamic Interplay of Microbes. Journal of Pharmaceutical Sciences, 107, 778-784. https://doi.org/10.1016/j.xphs.2017.10.031</mixed-citation></ref><ref id="scirp.114738-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Belenky, M.L. (1963) Elements of a Quantitative Assessment of the Pharmacological Effect. Science, Leningrad, 146 p.</mixed-citation></ref><ref id="scirp.114738-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Albert, A. (1987) Selective Toxicity, Part II. Medicine, Moscow, 49-56.</mixed-citation></ref><ref id="scirp.114738-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sanotsky, I.V. (1970) Methods for Determining the Toxicity and Hazard of Chemicals (Toxicometry). Medicine, Moscow, 219-225.</mixed-citation></ref><ref id="scirp.114738-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Sanotsky, I.V. and Ulanova, I.P. (1976) The Criterion of Harm in Hygiene and Toxicology in Assessing the Hazard of Chemical Compounds. Medicine, Moscow, 76-81.</mixed-citation></ref><ref id="scirp.114738-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Bear, L.I. (1977) Pesticide Handbook. Harvest, Kiev, 448-450.</mixed-citation></ref><ref id="scirp.114738-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Litchfield, J.T. and Wilcoxon, F.J. (1949) Asimplified Method of Evaluating Dose-Effect Experiments. Journal of Pharmacology and Experimental Therapeutics, 96, 99-113.</mixed-citation></ref><ref id="scirp.114738-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Roth, Z. (1960) Physiologia Bogtmoslovenica. Praga, 125-128.</mixed-citation></ref><ref id="scirp.114738-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Kudrin, A.N. and Ponamareva, G.T. (1967) Application of Mathematics in Experimental and Clinical Medicine. Meditsina Publishers, Moscow, 26-142.</mixed-citation></ref><ref id="scirp.114738-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Izmerov, N.F., Sonotsky, N.V. and Sidorov, K.K. (1977) Parameters of Toxometry of Industrial Poisons with a Single Exposure (Reference Book). Medicine, Moscow, 34-36.</mixed-citation></ref><ref id="scirp.114738-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Vasiliev, D.A., Shcherbakov, A.A., Karpunina, L.V., Zolotukhin, S.N. and Shvidenko, I.G. (2003) Methods of General Bacteriology. Ulyanovsk, 17-23.</mixed-citation></ref></ref-list></back></article>